• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-148a-3p 是脊髓损伤后骨髓脂肪增多和骨丢失的候选介质。

MicroRNA-148a-3p is a candidate mediator of increased bone marrow adiposity and bone loss following spinal cord injury.

机构信息

Drexel University College of Medicine, Philadelphia, PA, United States.

Department of Rehabilitation Medicine, University of Minnesota School of Medicine, Minneapolis, MN, United States.

出版信息

Front Endocrinol (Lausanne). 2022 Aug 5;13:910934. doi: 10.3389/fendo.2022.910934. eCollection 2022.

DOI:10.3389/fendo.2022.910934
PMID:35992108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9388741/
Abstract

Spinal cord injury is often followed by osteoporosis characterized by rapid and severe bone loss. This leads to an increased risk of osteoporotic fracture in people with spinal cord injury, resulting in increased healthcare costs, morbidity, and mortality. Though it is common, the mechanisms underlying this osteoporosis are not completely understood and treatment options are limited. No biomarkers have been identified for predicting fracture risk. In this study, we sought to investigate microRNA mediated mechanisms relating to osteoporosis following spinal cord injury. We studied subjects with acute SCI (n=12), chronic SCI (n=18), and controls with no SCI (n=23). Plasma samples from all subjects underwent transcriptomic analysis to quantify microRNA expression, after which miR-148a-3p was selected for further study. We performed CT scans of the knee on all subjects with SCI and analyzed these scans to quantify bone marrow adipose tissue volume. MiR-148a-3p was upregulated in subjects with acute SCI vs chronic SCI, as well as in acute SCI vs no SCI. Subjects with chronic SCI had greater levels of marrow adiposity in the distal femoral diaphysis compared to subjects with acute SCI. MiR-148a-3p levels were negatively associated with distal femoral diaphysis marrow adiposity. A multivariable model showed that miR-148a-3p and BMI explained 24% of variation in marrow adiposity. A literature search revealed that miR-148a-3p has multiple bone and fat metabolism related targets. Our findings suggest that miR-148a-3p is a mediator of osteoporosis following spinal cord injury and a potential future therapeutic target.

摘要

脊髓损伤常伴有骨质疏松症,其特征是骨量迅速和严重流失。这导致脊髓损伤患者发生骨质疏松性骨折的风险增加,从而增加医疗保健成本、发病率和死亡率。尽管这种情况很常见,但导致这种骨质疏松症的机制尚不完全清楚,治疗选择也有限。目前尚未确定用于预测骨折风险的生物标志物。在这项研究中,我们试图研究与脊髓损伤后骨质疏松症相关的 microRNA 介导的机制。我们研究了急性脊髓损伤(n=12)、慢性脊髓损伤(n=18)和无脊髓损伤的对照组(n=23)受试者。所有受试者的血浆样本均进行了转录组分析,以定量 microRNA 表达,之后选择 miR-148a-3p 进行进一步研究。我们对所有脊髓损伤受试者进行了膝关节 CT 扫描,并对这些扫描进行了分析,以定量骨髓脂肪组织体积。与慢性 SCI 相比,急性 SCI 受试者以及急性 SCI 与无 SCI 相比,miR-148a-3p 表达上调。与急性 SCI 受试者相比,慢性 SCI 受试者的远端股骨骨干骨髓脂肪含量更高。miR-148a-3p 水平与远端股骨骨干骨髓脂肪含量呈负相关。多变量模型显示,miR-148a-3p 和 BMI 可以解释骨髓脂肪含量变化的 24%。文献检索显示,miR-148a-3p 有多个与骨和脂肪代谢相关的靶标。我们的研究结果表明,miR-148a-3p 是脊髓损伤后骨质疏松症的一种介质,也是未来潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/9388741/79a0aaef7f90/fendo-13-910934-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/9388741/3820855dbd3d/fendo-13-910934-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/9388741/1801f06f71ef/fendo-13-910934-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/9388741/79a0aaef7f90/fendo-13-910934-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/9388741/3820855dbd3d/fendo-13-910934-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/9388741/1801f06f71ef/fendo-13-910934-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/9388741/79a0aaef7f90/fendo-13-910934-g003.jpg

相似文献

1
MicroRNA-148a-3p is a candidate mediator of increased bone marrow adiposity and bone loss following spinal cord injury.微小 RNA-148a-3p 是脊髓损伤后骨髓脂肪增多和骨丢失的候选介质。
Front Endocrinol (Lausanne). 2022 Aug 5;13:910934. doi: 10.3389/fendo.2022.910934. eCollection 2022.
2
MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women.微小RNA-148a(骨稳态的表观遗传调节因子)在绝经后骨质疏松症女性的血浆中水平升高。
Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):519-526. doi: 10.1007/s00508-016-1141-3. Epub 2016 Nov 29.
3
MicroRNA-92a-3p enhances functional recovery and suppresses apoptosis after spinal cord injury via targeting phosphatase and tensin homolog.微小 RNA-92a-3p 通过靶向磷酸酶和张力蛋白同源物增强脊髓损伤后的功能恢复并抑制细胞凋亡。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20192743.
4
microRNA-148a-3p-targeting p300 protects against osteoblast differentiation and osteoporotic bone reconstruction.miRNA-148a-3p 靶向 p300 保护成骨细胞分化和骨质疏松性骨重建。
Regen Med. 2021 May;16(5):435-449. doi: 10.2217/rme-2020-0006. Epub 2021 May 18.
5
MiR-212-3p improves rat functional recovery and inhibits neurocyte apoptosis in spinal cord injury models via PTEN downregulation-mediated activation of AKT/mTOR pathway.miR-212-3p 通过下调 PTEN 介导的 AKT/mTOR 通路的激活,改善大鼠脊髓损伤模型的功能恢复并抑制神经细胞凋亡。
Brain Res. 2021 Oct 1;1768:147576. doi: 10.1016/j.brainres.2021.147576. Epub 2021 Jul 1.
6
MicroRNA-489-3p inhibits neurite growth by regulating PI3K/AKT pathway in spinal cord injury.微小RNA-489-3p通过调节脊髓损伤中的PI3K/AKT通路抑制神经突生长。
Pharmazie. 2017 May 1;72(5):272-278. doi: 10.1691/ph.2017.6972.
7
Role of microRNA-19b-3p on osteoporosis after experimental spinal cord injury in rats.微小RNA-19b-3p在大鼠实验性脊髓损伤后骨质疏松中的作用
Arch Biochem Biophys. 2022 Apr 15;719:109134. doi: 10.1016/j.abb.2022.109134. Epub 2022 Jan 24.
8
microRNA-148a-3p in extracellular vesicles derived from bone marrow mesenchymal stem cells suppresses SMURF1 to prevent osteonecrosis of femoral head.骨髓间充质干细胞来源的细胞外囊泡中的 microRNA-148a-3p 抑制 SMURF1 以防止股骨头坏死。
J Cell Mol Med. 2020 Oct;24(19):11512-11523. doi: 10.1111/jcmm.15766. Epub 2020 Sep 1.
9
microRNA-331-3p attenuates neuropathic pain following spinal cord injury via targeting RAP1A.微小 RNA-331-3p 通过靶向 RAP1A 减轻脊髓损伤后的神经性疼痛。
J Biol Regul Homeost Agents. 2020 Jan-Feb;34(1):25-37. doi: 10.23812/19-291-A.
10
Femoral bone marrow adiposity and cortical bone cross-sectional areas in men with motor complete spinal cord injury.男性运动性完全性脊髓损伤患者的股骨骨髓脂肪含量和皮质骨横截面积。
PM R. 2013 Nov;5(11):939-48. doi: 10.1016/j.pmrj.2013.05.006. Epub 2013 May 15.

引用本文的文献

1
Laboratory-based Biomarkers for Risk Prediction, Auxiliary Diagnosis and Post-operative Follow-up of Osteoporotic Fractures.用于骨质疏松性骨折风险预测、辅助诊断及术后随访的实验室生物标志物
Curr Osteoporos Rep. 2025 Apr 8;23(1):19. doi: 10.1007/s11914-025-00914-5.
2
MicroRNA Profile of Mouse Adipocyte-Derived Extracellular Vesicles.小鼠脂肪细胞衍生细胞外囊泡的 microRNA 谱。
Cells. 2024 Aug 1;13(15):1298. doi: 10.3390/cells13151298.
3
Circulating and extracellular vesicle-derived microRNAs as biomarkers in bone-related diseases.

本文引用的文献

1
hsa-MiR-19a-3p and hsa-MiR-19b-3p Are Associated with Spinal Cord Injury-Induced Neuropathic Pain: Findings from a Genome-Wide MicroRNA Expression Profiling Screen.hsa-MiR-19a-3p和hsa-MiR-19b-3p与脊髓损伤诱导的神经性疼痛相关:全基因组微小RNA表达谱筛查结果
Neurotrauma Rep. 2021 Sep 14;2(1):424-439. doi: 10.1089/neur.2021.0011. eCollection 2021.
2
miR-338-5p Levels and Cigarette Smoking are Associated With Neuropathic Pain Severity in Individuals With Spinal Cord Injury: Preliminary Findings From a Genome-Wide microRNA Expression Profiling Screen.miR-338-5p 水平和吸烟与脊髓损伤患者神经性疼痛严重程度相关:全基因组 microRNA 表达谱筛选的初步发现。
Arch Phys Med Rehabil. 2022 Apr;103(4):738-746. doi: 10.1016/j.apmr.2021.09.005. Epub 2021 Oct 27.
3
循环和细胞外囊泡衍生的 microRNAs 作为与骨相关疾病的生物标志物。
Front Endocrinol (Lausanne). 2023 May 24;14:1168898. doi: 10.3389/fendo.2023.1168898. eCollection 2023.
MicroRNAs: roles in cardiovascular development and disease.微小 RNA:在心血管发育和疾病中的作用。
Cardiovasc Pathol. 2021 Jan-Feb;50:107296. doi: 10.1016/j.carpath.2020.107296. Epub 2020 Oct 3.
4
Identification of differentially expressed microRNAs in the bone marrow of osteoporosis patients.骨质疏松症患者骨髓中差异表达的微小RNA的鉴定
Am J Transl Res. 2019 May 15;11(5):2940-2954. eCollection 2019.
5
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism.1型糖尿病患者血清miR-148a和miR-21-5p水平升高,且与骨强度和代谢标志物相关。
Noncoding RNA. 2018 Nov 27;4(4):37. doi: 10.3390/ncrna4040037.
6
MiR-148a regulates bone marrow mesenchymal stem cells-mediated fracture healing by targeting insulin-like growth factor 1.微小RNA-148a通过靶向胰岛素样生长因子1调控骨髓间充质干细胞介导的骨折愈合。
J Cell Biochem. 2019 Feb;120(2):1350-1361. doi: 10.1002/jcb.27121. Epub 2018 Oct 18.
7
Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.微小 RNA 作为结直肠癌潜在诊断和预后标志物的相关性。
Int J Mol Sci. 2018 Sep 27;19(10):2944. doi: 10.3390/ijms19102944.
8
Mesenchymal Stem Cells: Cell Fate Decision to Osteoblast or Adipocyte and Application in Osteoporosis Treatment.间充质干细胞:向成骨细胞或脂肪细胞的细胞命运决定及其在骨质疏松症治疗中的应用。
Int J Mol Sci. 2018 Jan 25;19(2):360. doi: 10.3390/ijms19020360.
9
miR-148a-3p regulates adipocyte and osteoblast differentiation by targeting lysine-specific demethylase 6b.微小RNA-148a-3p通过靶向赖氨酸特异性去甲基化酶6b调控脂肪细胞和成骨细胞分化。
Gene. 2017 Sep 5;627:32-39. doi: 10.1016/j.gene.2017.06.002. Epub 2017 Jun 3.
10
MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women.微小RNA-148a(骨稳态的表观遗传调节因子)在绝经后骨质疏松症女性的血浆中水平升高。
Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):519-526. doi: 10.1007/s00508-016-1141-3. Epub 2016 Nov 29.